Emerson (EMR) PT Raised to $109 at Wolfe Research
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $170.37 +2.39%
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Wolfe Research analyst Nigel Coe raised the price target on Emerson (NYSE: EMR) to $109.00 (from $107.00) while maintaining a Peerperform rating.
You May Also Be Interested In
- Emerson Electric (EMR) Tops Q4 EPS by 1c ; Offers Guidance
- Emerson (EMR) PT Lowered to $140 at Morgan Stanley
- Emerson Reports Fourth Quarter and Full Year 2026 Results; Provides Initial 2027 Outlook
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
